By David Wild
Originally published by our sister publication, Gastroenterology Endoscopy News
Researchers have identified a number of risk factors for treatment failure after fecal microbiota transplantation (FMT) for Clostridioides difficile infection (CDI), some of them modifiable.
“Although [FMT] is a powerful therapy for individuals who develop recurrent CDI (rCDI), 10% to 15% of patients still fail to recover following FMT,” Alexa Weingarden, MD, PhD, a gastroenterology